BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The supply of Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir Disoproxil 245mg Tablets (Eviplera®) to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Gilead Sciences Ltd | 02543818 | - | 1 lot Lot 1 | LOBBYIST Ovid Consulting Ltd (4 quarters) Portland PR Limited (1 quarter) WA Communications Ltd (1 quarter) |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £3,936,367 initial term | 1 single bid — no competition | Gilead Sciences Ltd | complete |
Weightings from the notice.
Government spending data: This supplier has received £163,733,149 in 687 payments (over £25k) from Department of Health and Social Care, Manchester University NHS Foundation Trust, The Christie NHS Foundation Trust, Plymouth Hospitals NHS Trust, Guy's and St Thomas' NHS FT and 5 more public bodies (2018-09-19 to 2026-03-31). View full payment history →